Vimarsana
Biggest News Aggregation in the World

Page 7 - Urovant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Urovant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Urovant Sciences Today - Breaking & Trending Today

Six new members join the EUCOPE network - Vimarsana News

Six new members join the EUCOPE network

Published: June 28, 2022

BioPharma

Source: biopharmadive.com
Related Topics:
United KingdomBruxelles CapitaleStephane MartinAlexander RoussanovLaboratoire CevidraArnold PorterRuth NasrJustine GalletEuropean Confederation Of Pharmaceuticals EntrepreneursGovernment AffairsAmylyx PharmaceuticalsPart Of The Destaing Participations GroupUrovant SciencesBusiness DevelopmentEuropean ConfederationPharmaceuticals EntrepreneursMembers MeetingBavarian NordicGeneral Alexander NatzLugdivine Le DezPatient AdvocacySenior DirectorWorld MarketsMarket AccessDestaing Participations Group
Urovant Sciences, Inc.: Urovant Sciences Presents New Data from EMPOWUR Study, Advancing Knowledge of the Treatment of Overactive Bladder at the 2022 American Urological Association Meeting - Vimarsana News

Urovant Sciences, Inc.: Urovant Sciences Presents New Data from EMPOWUR Study, Advancing Knowledge of the Treatment of Overactive Bladder at the 2022 American Urological Association Meeting

Published: May 15, 2022

New analyses of data from the Phase 3 EMPOWUR Extension Study of GEMTESA (vibegron) 75 mg provided additional insight into the long-term effects of the product. These data were featured in podium

Source: finanznachrichten.de
Related Topics:
United StatesSumitovant BiopharmaSumitomo PharmaMaya FrutigerAlana Darden PowellDavid StaskinJeffrey FrankelDrug AdministrationAmerican Urological AssociationUrovant Sciences GmbSeattle Urology Research CenterCorporate CommunicationsTufts University School Of MedicineUs Public HealthUrovant SciencesSumitovant Biopharma LtdHead Of Corporate CommunicationsPatient Global ImpressionNew OrleansSef KurstjensExecutive Vice PresidentChief Medical OfficerMedical DirectorTerm EfficacyOveractive Bladder
Urovant Sciences, Inc.: Urovant Sciences Presents Interim Data from Phase 2a Study of Investigational Novel Gene Therapy, URO-902, Supporting Safety, Tolerability, and Efficacy Endpoints at 2022 American Urological Association Meeting - Vimarsana News

Urovant Sciences, Inc.: Urovant Sciences Presents Interim Data from Phase 2a Study of Investigational Novel Gene Therapy, URO-902, Supporting Safety, Tolerability, and Efficacy Endpoints at 2022 American Urological Association Meeting

Published: May 13, 2022

Interim 12-week analysis from an ongoing Phase 2a trial of an investigational novel gene therapy product (plasmid human cDNA encoding maxi-K channel) showed clinically relevant improvement in the

Source: finanznachrichten.de
Related Topics:
United StatesSumitovant BiopharmaKenneth PetersSumitomo PharmaMaya FrutigerAlana Darden PowellDepartment Of Urology At Beaumont HospitalAmerican Urological AssociationUrovant Sciences GmbCorporate CommunicationsUs Public HealthPelvic Health CenterUrovant SciencesSumitovant Biopharma LtdHead Of Corporate CommunicationsPlenary PresentationNew OrleansPrincipal InvestigatorBeaumont HospitalRoyal OakMedical DirectorBeaumont WomenOakland University William Beaumont SchoolSef KurstjensExecutive Vice President
Egle Therapeutics SAS: Egle Therapeutics Appoints Pierre Legault as Chairman and Board Member - Vimarsana News

Egle Therapeutics SAS: Egle Therapeutics Appoints Pierre Legault as Chairman and Board Member

Published: May 5, 2022

Egle Therapeutics SAS (Egle), an emerging biotechnology company dedicated to developing novel immunotherapies for oncology and autoimmune diseases, is pleased to announce Pierre Legault as Chairman

Source: finanznachrichten.de
Related Topics:
Kostenloser WertpapierhandelEliane PiaggioAmolyt PharmaArtios PharmaPierre LegaultInstitut CurieShulakova Deborah CockerillProsidion LtdSyndax PharmaceuticalsUrovant SciencesSciad Communications LtdAegle TherapeuticsLuc BobletBicycle TherapeuticsEdmunds Darya Shulakova Deborah CockerillCommunications Ltd
Truvian Sciences Appoints Top Industry Veterans to its Leadership Team as it Prepares to Commercialize its Automated Benchtop Blood Testing System - Vimarsana News

Truvian Sciences Appoints Top Industry Veterans to its Leadership Team as it Prepares to Commercialize its Automated Benchtop Blood Testing System

Published: April 21, 2022

Truvian Sciences Appoints Top Industry Veterans to its Leadership Team as it Prepares to Commercialize its Automated Benchtop Blood Testing System - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com
Related Topics:
United StatesNew DelhiMechanical EngineeringDainippon Sumitomo PharmaEric ZiegerDena MarrinucciJoe BensonAjay BansalJeff HawkinsAjay SrinivasanTyler JensenTruvian SciencesHead Of Business Development At Urovant SciencesVirginia UniversityRady School Of ManagementDesign Engineering TechnologyFlorida Atlantic UniversityArena PharmaceuticalsKellogg Graduate School Of ManagementIndian Institute Of TechnologyAmylin PharmaceuticalsOperations ResearchDrug AdministrationHarvard Business SchoolBrigham Young University